Sereno, M. et al. (2021) Inclusion of multiple high‐risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma. Histopathology, 78(6), pp. 838-848. (doi: 10.1111/his.14301) (PMID:33155719) (PMCID:PMC8247971)

Rankin, A. J. , Cannon, E., Gillis, K. , Crosby, J., Mark, P. B. , Geddes, C. C., Fox, J. G., Mackinnon, B., McQuarrie, E. and Kipgen, D. (2020) Predicting outcome in acute interstitial nephritis: a case series examining the importance of histological parameters. Histopathology, 76(5), pp. 698-706. (doi: 10.1111/his.14031) (PMID:31691330)

Leung, E. Y. , McMahon, J. D., McLellan, D. R., Syyed, N., McCarthy, C. E., Nixon, C., Orange, C., Brock, C., Hunter, K. D. and Adams, P. D. (2017) DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity. Histopathology, 71(4), pp. 522-528. (doi: 10.1111/his.13260) (PMID:28543539)

Park, J. H. , Roxburgh, C. S.D. , Edwards, J. , Horgan, P. G. and McMillan, D. C. (2017) In reply to "Hynes S.O. et al. Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study". Histopathology, 71(2), pp. 326-327. (doi: 10.1111/his.13195) (PMID:28226191)

Wong, N. A.C.S., Adamczyk, L. A., Evans, S., Cullen, J., Oniscu, A. and Oien, K. A. (2017) A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma. Histopathology, 71(1), pp. 34-41. (doi: 10.1111/his.13194) (PMID:28226180)

Cheng, K. K.W., Dickson, A., Gujam, F. J.A., McMillan, D. C. and Edwards, J. (2017) The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer. Histopathology, 70(5), pp. 782-797. (doi: 10.1111/his.13134) (PMID:27891654)

Allan, E., Miller, R. and Going, J. (2015) Aneusomy detected by fluorescencein-situhybridization has high positive predictive value for Barrett's dysplasia. Histopathology, 67(4), pp. 451-456. (doi: 10.1111/his.12679) (PMID:25735914)

Doyle, B. et al. (2013) Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology, 62(3), pp. 505-510. (doi: 10.1111/his.12014)

Sanders, D.S.A., Grabsch, H., Harrison, R., Bateman, A., Going, J., Goldin, R., Mapstone, N., Novelli, M., Walker, M.M. and Jankowski, J. (2012) Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit. Histopathology, 61(5), pp. 795-800. (doi: 10.1111/j.1365-2559.2012.04288.x)

Mohammed, Z.M.A., Going, J.J., McMillan, D.C. , Orange, C., Mallon, E., Doughty, J.C. and Edwards, J. (2012) Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. Histopathology, 61(4), pp. 675-684. (doi: 10.1111/j.1365-2559.2012.04280.x)

Mohammed, Z.M.A., Edwards, J. , Orange, C., Mallon, E., Doughty, J., McMillan, D.C. and Going, J.J. (2012) Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis. Histopathology, 61(2), pp. 283-292. (doi: 10.1111/j.1365-2559.2012.04244.x)

Going, J.J. (2011) Observer prediction of HER2 amplification in HercepTest 2+breast cancers as a potential audit instrument. Histopathology, 59(2), pp. 333-335. (doi: 10.1111/j.1365-2559.2011.03879.x)

Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)

Chetty, R. and Serra, S. (2010) Response to: Pancreatic intraductal lesions with possible relationship with gastric type intraductal papillary mucinous neoplasm: pyloric gland-type intraductal tubular adenoma and intraductal oncocytic papillary neoplasm. Histopathology, 56(7), p. 969. (doi: 10.1111/j.1365-2559.2010.03569.x)

Kirkegaard, T., Witton, C.J., Edwards, J., Nielsen, K.V., Jensen, L.B., Campbell, F.M., Cooke, T.G. and Bartlett, J.M.S. (2010) Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. Histopathology, 56(2), pp. 203-211. (doi: 10.1111/j.1365-2559.2009.03467.x)

Housley, S. L., Lindsay, R. S. , Young, B., McConachie, M., Mechan, D., Baty, D., Christie, L., Rahilly, M., Qureshi, K. and Fleming, S. (2010) Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene. Histopathology, 56(3), pp. 405-408. (doi: 10.1111/j.1365-2559.2010.03482.x)

Clark, R.R., Soutar, D. and Hunter, K.D. (2010) A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology, 57(1), pp. 138-146. (doi: 10.1111/j.1365-2559.2010.03593.x)

Mitra, A. et al. (2009) Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology, 55(6), pp. 696-704. (doi: 10.1111/j.1365-2559.2009.03448.x)

Kirkegaard, T. et al. (2008) Genetic alterations of CCND1 and EMSY in breast cancers. Histopathology, 52(6), pp. 698-705.

Digby, S., MacDuff, E., Blessing, K., Holmes, S. and Holmes, S. (2008) Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity. Histopathology, 52(4), pp. 531-534.

Going, J.J., Nixon, C., Dornan, E.S., Boner, W. , Donaldson, M.M. and Morgan, I.M. (2007) Aberrant expression of TopBP1 in breast cancer. Histopathology, 50(4), pp. 418-424. (doi: 10.1111/j.1365-2559.2007.02622.x)

Going, J. (2006) Counting cells made easier. Histopathology, 49(3), pp. 309-311. (doi: 10.1111/j.1365-2559.2006.02458.x)

Kirkegaard, T., Edwards, J. , Tovey, S., McGlynn, L.M., Krishna, S.N., Mukherjee, R., Tam, L., Munro, A.F., Dunne, B. and Bartlett, J.M. (2006) Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology, 48(7), pp. 787-794. (doi: 10.1111/j.1365-2559.2006.02412.x)

Shearer, C., Going, J., Neilson, L., Mackay, C. and Stuart, R. (2005) Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease. Histopathology, 47(3), pp. 268-275. (doi: 10.1111/j.1365-2559.2005.02219.x)

Witton, C., Hawe, S., Cooke, T. and Bartlett, J. (2004) Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology, 45, pp. 47-54.

de Silva, M., McMahon, A. , Paterson, L. and Reid, R. (2003) Identification of poorly differentiated synovial sarcoma: a comparison of clinicopathological and cytogenetic features with those of typical synovial sarcoma. Histopathology, 43, pp. 220-230.

Nandini, C., Lindop, G., Gillen, D., Hendry, A. and Oien, K. (2001) Iron-induced oesophageal injury and pigmentation. Histopathology, 39(6), pp. 643-645.

Dunne, B. and Going, J. (2001) Scoring nuclear pleomorphism in breast cancer. Histopathology, 39(3), pp. 259-265. (doi: 10.1046/j.1365-2559.2001.01220.x)

Koeppen, H., Wright, B., Burt, A., Quirke, P., McNicol, A., Dybdal, N., Sliwkowski, M. and Hillan, K. (2001) Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology, 38, pp. 96-104.

Adams, J.H., Doyle, D., Ford, I. , Gennarelli, T.A., Graham, D.I. and McLellan, D.R. (1989) Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology, 15(1), pp. 49-59. (doi: 10.1111/j.1365-2559.1989.tb03040.x)